Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT05001646
NCT05001646UnknownPhase 2

Clinical and Molecular Impact of In-home Resonance-based Electromagnetic Field Protection Device Usage in Healthy Individuals

TruDiagnostic0 sites44 target enrollmentStarted: March 1, 2022Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Sponsor
Enrollment
44
Primary Endpoint
Epigenetic Testing
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This is a prospective, single group, self-controlled study to evaluate the clinical and molecular impact of continuous in-home resonance-based electromagnetic field (EMF) protection device usage in healthy individuals.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
30 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Any sex, gender orientation, and ethnicity
  • •Between ages 30 and 70
  • •Must be willing and able to participate in venipuncture, health history and clinical assessments, passive monitoring (Oura ring), and continuous in-home Blushield device usage

Exclusion Criteria

  • •Significant change in diagnosis and/or treatment of major illness or injury within 2 years prior to screening, e.g., diabetes, cancer, cardiovascular disease, psychiatric condition
  • •Any ongoing immune system concerns or immunodeficiency disease
  • •History of any viral illness in preceding year
  • •Body mass index (BMI) > 35 kg/m2
  • •Presence of active infection
  • •Any other illness, disorder, alcohol or chemical dependence that in the opinion of investigators would render study participation unsuitable
  • •Unable or unwilling to provide required biological sample
  • •Unable or unwilling to avoid pregnancy during study period

Arms & Interventions

In-home EMF protection device

Experimental

Intervention: In-home resonance-based electromagnetic field protection device (Device)

Outcomes

Primary Outcomes

Epigenetic Testing

Time Frame: Change from baseline to 12 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
TruDiagnostic
Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials

Unknown
Phase 3
Effects of Home-based Pulmonary Rehabilitation in Patients With Severe or Very Severe Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease
NCT01198288Associazione Riabilitatori Insufficienza Respiratoria182
Unknown
Not Applicable
Home BIA Management System in Patients With Heart FailureHeart Failure，Congestive
NCT05177081Korea University Guro Hospital40
Recruiting
Not Applicable
Impact of a Self-rehabilitation and Tele-rehabilitation Program on the Post-stroke Care PathwayHemorrhagic Unilateral Cortico-subcortical Hemispheric StrokeIschemic Stroke
NCT06443840Association APPROCHE40
Completed
Not Applicable
Effect of exercise in patients with cardiac diseaseCardiac patients rehabilitation.
IRCT20210927052610N1Yazd University of Medical Sciences62
Completed
Not Applicable
The effect of home electrical stimulation and intra-operative femoral nerve blockage on outcomes after anterior cruciate ligament reconstructioAthletes with a torn ACL (anterior cruciate ligament)Injury, Occupational Diseases, Poisoning
ISRCTN15816734Empi, Inc120